# MDClone

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdclone

- Industry: Healthcare IT
- Headquarters: Beersheba, Israel
- Website: www.mdclone.com
- Total disclosed funding: $94M
- Latest round: Series C (Mar 1, 2022)
- Investors on record: 5

## About

MDClone Ltd. is a healthcare data analytics company that provides innovative solutions for organizations seeking to explore and analyze health data securely and efficiently through its ADAMS platform.Founded in 2016 and headquartered in Beersheba, Israel, MDClone Ltd. specializes in data-driven healthcare insights using its ADAMS platform. The company has completed 4 deals, the most recent being a Series C funding round in March 2022, where they raised USD 63.00 mn with participation from notable investors including Lightspeed Venture Partners, OrbiMed Advisors, Viola Group, Warburg Pincus, and aMoon.MDClone's primary offering is the ADAMS platform, a self-service healthcare data exploration environment that enables organizations to access, analyze, and collaborate on health data insights in real-time. This innovative platform leverages synthetic data to facilitate deep exploration of healthcare data while ensuring security and compliance. The end use cases include improving patient outcomes, operational efficiencies, and supporting proactive care management, particularly in areas such as kidney disease management and the detection of intracranial hemorrhage using artificial intelligence. MDClone serves a diverse client base that includes healthcare institutions, research facilities, and life sciences organizations across various geographical markets, including the United States and Europe, providing them with tools to address complex data challenges and enhance decision-making capabilities.MDClone employs a subscription-based revenue model designed for healthcare organizations and research institutions utilizing its ADAMS platform. Clients typically engage in annual contracts that grant access to the platform's suite of services, including data preparation, visualization, and analytics tools. Transactions are structured around subscription fees based on service levels and user counts. The company may also enter partnerships with healthcare systems and academic institutions to develop tailored solutions, solidifying its presence in the healthcare analytics market.In March 2022, MDClone Ltd. raised USD 63.00 mn in Series C funding to accelerate the expansion of its transformative healthcare data solutions. The company plans to invest in new regional markets while continuing to develop the existing platform and expand into new verticals, including Life Science and Real World Evidence (RWE).

## Funding rounds

- Series C, Mar 1, 2022, $63M — Lightspeed Venture Partners, OrbiMed Advisors, Warburg Pincus, Viola Group, aMoon
- Series B, Aug 22, 2019, $26M — Lightspeed Venture Partners, OrbiMed Advisors, aMoon
- Seed, Jul 28, 2016, $5M — OrbiMed Advisors

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Seed, Series B, Series C
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series B, Series C
- aMoon (https://capitalatlas.ai/funds/amoon) — Series B, Series C
- Warburg Pincus (https://capitalatlas.ai/funds/warburg-pincus) — Series C
- Viola Group (https://capitalatlas.ai/funds/viola-group) — Series C